December 9, 2022

APC briefs BOPs on GFI 256, DTE

This week, APC sent state boards of pharmacy two briefing memos to provide the boards of pharmacy with background, context, and guidance.

One memo focuses on the FDA Center for Veterinary Medicine’s GFI on animal compounding and how that guidance may interact with or conflict with state law or regulation.

The other memo addresses FDA’s recent clarification of its stance on desiccated thyroid extract compounding and urges state boards to adopt the same “enforcement discretion” approach as FDA on this issue.

Please reach out to your state’s Board of Pharmacy members and director and urge them to attend to the memos. And of course, let them know that representatives of APC are happy to speak to the Board about these issues if invited. Lastly, share any feedback you get with us at